SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039833
Filing Date
2023-05-15
Accepted
2023-05-15 16:30:28
Documents
32
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_raphaelpharma.htm   iXBRL 10-Q 256185
2 CERTIFICATION f10q0323ex31-1_raphael.htm EX-31.1 9869
3 CERTIFICATION f10q0323ex31-2_raphael.htm EX-31.2 10363
4 CERTIFICATION f10q0323ex32-1_raphael.htm EX-32.1 3447
5 CERTIFICATION f10q0323ex32-2_raphael.htm EX-32.2 3512
  Complete submission text file 0001213900-23-039833.txt   1320051

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cik0000141539-20230331.xsd EX-101.SCH 20423
7 XBRL CALCULATION FILE cik0000141539-20230331_cal.xml EX-101.CAL 11703
8 XBRL DEFINITION FILE cik0000141539-20230331_def.xml EX-101.DEF 60277
9 XBRL LABEL FILE cik0000141539-20230331_lab.xml EX-101.LAB 154419
10 XBRL PRESENTATION FILE cik0000141539-20230331_pre.xml EX-101.PRE 65897
26 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_raphaelpharma_htm.xml XML 55830
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

IRS No.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53002 | Film No.: 23923105
SIC: 2833 Medicinal Chemicals & Botanical Products